Peter Novodvorsky (Peter Novodvorský)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Topics

Glycemic Control

Systemic Lupus Erythematosus

Top Venues

Diabetes therapy : research, treatment and education of diabetes and related disorders

World journal of surgery

Expert opinion on drug safety

BMJ case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Peter Novodvorsky, Lenka Thieme, Ivana Laňková, Miloš Mráz, Zoltán J Taybani, Balázs Bótyik, Péter Stella, Miroslav Vytasil, Felipe Lauand, Mireille Bonnemaire, Martin Haluzík
The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial-Study Design and Protocol. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (6) (2024)
Peter Novodvorsky, Lenka Thieme, Ivana Laňková, Miloš Mráz, Zoltán J Taybani, Balázs Bótyik, Péter Stella, Miroslav Vytasil, Felipe Lauand, Mireille Bonnemaire, Martin Haluzík
The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial-Study Design and Protocol. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (6) (2024)
Peter Novodvorsky, Lenka Thieme, Ivana Laňková, Miloš Mráz, Zoltán J Taybani, Balázs Bótyik, Péter Stella, Miroslav Vytasil, Felipe Lauand, Mireille Bonnemaire, Martin Haluzík
The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial-Study Design and Protocol. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (6) (2024)
Peter Novodvorsky, Lenka Thieme, Ivana Laňková, Miloš Mráz, Zoltán J Taybani, Balázs Bótyik, Péter Stella, Miroslav Vytasil, Felipe Lauand, Mireille Bonnemaire, Martin Haluzík
The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial-Study Design and Protocol. Diabetes therapy : research, treatment and education of diabetes and related disorders 15 (6) (2024)
Peter Novodvorsky, Lenka Thieme, Ivana Laňková, Miloš Mráz, Zoltán J Taybani, Balázs Bótyik, Péter Stella, Miroslav Vytasil, Felipe Lauand, Mireille Bonnemaire, Martin Haluzík
The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial-Study Design and Protocol. Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)
Mariana Rončáková, Arash Davani, Veronika Mikušová, Ivana Ságová, Peter Novodvorsky, Emil Martinka
Prevalence of Positivity for Diabetes-Associated Autoantibodies in Individuals with Type 2 Diabetes and Their Further Characterisation: Cross-sectional Study from Slovakia. Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)
Peter Novodvorsky, Andrew F Lowry, C Beverly B Lim, Sabapathy P Balasubramanian
Serum Magnesium Measurements After Parathyroidectomy for Primary Hyperparathyroidism: Should It be Routine? World journal of surgery 44 (6) (2021)
Peter Novodvorsky, Martin Haluzík
An update on the safety of insulin-GLP-1 receptor agonist combinations in type 2 diabetes mellitus. Expert opinion on drug safety (2021)
Peter Novodvorsky, Muhammad Fahad Arshad, Susan Heyes, Rajiv Gandhi
Non-healing 'diabetic' ulceration which turned out to be a lentiginous melanoma: a case from a diabetic foot clinic. BMJ case reports 12 (1) (2019)